(PDF) Toll-Like Receptor 9 (TLR9) or TLR3 Adjuvants to

Toll-Like Receptor 9 (TLR9) or TLR3 Adjuvants to Promote Cancer Vaccine–induced Effector T Cell Expansion

Science-Business eXchange

doi 10.1038/scibx.2013.1207

Full Text

Abstract

Available in full text

Date

October 1, 2013

Authors

Unknown

Publisher

Springer Science and Business Media LLC